八十岁患者的外科瘤紧急情况
Alberto Friziero1, Cosimo Sperti2, Federica Riccio1
1Department of Surgery, Oncology and Gastroenterology, 1st Surgical Clinic, University of Padua, Padua, Italy.
Frontiers in oncology
|December 14, 2023
概括
高龄不是紧急瘤手术中负面结果的风险因素. 专注于临床状况,血清白蛋白和乳酸脱酶 (LDH) 来预测这些关键患者的结果.
科学领域:
- 在瘤学瘤学.
- 急性护理手术急性护理手术
- 老年人手术是一门老年手术.
背景情况:
- 手术瘤紧急情况带来了高发病率和死亡率的重大挑战.
- 精确的患者选择至关重要,以避免不必要的侵入性手术.
- 调查晚年作为这一群体不良结果的风险因素是必不可少的.
研究的目的:
- 确定晚年 (80岁以上) 是否是急性腹部瘤病症紧急手术患者短期负面结果的风险因素.
- 在外科瘤紧急情况中确定短期死亡率的预测因素.
主要方法:
- 在2018-2022年期间,对102名接受紧急瘤手术的癌症患者进行了回顾性分析.
- 80岁以上的患者和年轻患者之间的结局的比较.
- 多变量逻辑回归分析以确定短期死亡风险因素.
主要成果:
- 八十岁老人和年轻患者之间30天或90天死亡率没有显著差异.
- 术后发病率和住院时间在各年龄组之间是相似的.
- 低血清白蛋白和乳酸脱酶 (LDH) 水平升高是短期死亡率的显著预测因素.
结论:
- 高龄不是紧急瘤手术的禁忌.
- 对于患有瘤紧急情况的八年龄人群,如果临床稳定,应考虑进行手术.
- 血清白蛋白和LDH水平是预测术后结果的有价值的生物标志物.
更多相关视频
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014
30.0K
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.7K
相关概念视频
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:21Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355